Connect
← Return to Options for Peritoneal Mets
Discussion
Comment receiving replies
@gsf , I'm in the MOONRAY clinical trial, https://www.clinicaltrials.gov/study/NCT06586515 .
It's a KRAS G12D inhibitor administered by oral tablets from Eli Lilly. I take 6 per day at bedtime, along with a pill to control nausea and diarrhea. Too soon for my first scan, but CA19-9 has gone down quite a bit.
The travel requirements aren't bad. The first month has a couple all-day trips to the center for hourly blood tests, but after that, it's about one trip per month.
Replies to "@gsf , I'm in the MOONRAY clinical trial, https://www.clinicaltrials.gov/study/NCT06586515 . It's a KRAS G12D inhibitor administered..."
@markymarkfl Thank you very much for the information on the clinical trial you are in! I wish you the very best of luck in the trial. I plan to look into the trial using the link you so kindly gave us. My wife's oncologist told us recently that, since my wife completed radiation (at Dana Farber in Boston) just recently, most trials won't take her until the next scan determines cancer progress (or lack thereof!). Scan won't take place until January, 2026. Thanks again!
Connect
@markymarkfl I hope the trial works great for you! Unfortunately, having been on RMC-9805 excluded me from most inhibitor trials (of which there are a lot now) so I am facing very limited options in clinical trials.